Bora Pharmaceuticals 2Q25 Operating Margin Expanded 5 Percentage Points, Reaching Quarterly High Since The Start of Integration in 4Q24; Strong Momentum Poised to Accelerate in 2H25 As Operational Efficiency Gains Materialize
HONG KONG SAR – Media OutReach Newswire – 8 August 2025 – Bora Pharmaceuticals (TWSE: 6472) today announced its financial results and operational highlights for second quarter of 2025. Quarterly Business and Financial Highlights · Company reported quarterly basic EPS of NT$5.95, with NT$1.81 from discontinued operations. OPEX was ~15% below guidance, aided by a […]
Read More









